LPCN – lipocine inc. (US:NASDAQ)
Stock Stats
News
5/1
08:00 am
lpcn
Medium
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154
4/27
02:04 am
lpcn
Low
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/19
02:07 am
lpcn
Low
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/11
11:21 am
lpcn
Medium
Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics) [Yahoo! Finance]
4/11
07:22 am
lpcn
Medium
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity [Yahoo! Finance]
11/8/2023
08:00 am
LPCN
-1.2%
MISS
8/10/2023
08:00 am
LPCN
-2.7%
MISS
5/1
09:00 am
lpcn
Low
Form 8-K Lipocine Inc. For: May 01
4/29
09:02 am
lpcn
Low
Form 8-K Lipocine Inc. For: Apr 29
4/26
05:21 pm
lpcn
Low
Form 8-K Lipocine Inc. For: Apr 26
4/26
05:16 pm
lpcn
Low
Form 424B5 Lipocine Inc.
4/26
06:09 am
lpcn
Low
Form EFFECT Lipocine Inc.
Show more
Top News Gainers
2/24 Lipocine Announces Regulatory Path Forward for TLANDO™ Resubmission 65.6%
2/25 Lipocine Announces $6 Million Registered Direct Offering Priced At-The-Market 13.8%
1/1 LIPOCINE EQUITY LOSS ALERT: ROSEN, A LEADING LAW FIRM, Reminds Lipocine Inc. Investors of Important January 14th Deadline in Securities Class Action - LPCN 8.9%
1/10 Form 8-K Lipocine Inc. For: Jan 10 8.0%
5/14 Lipocine Announces TLANDO™ NDA PDUFA Action Date of November 9, 2019 7.2%
4/10 Investors Who Bought Lipocine (NASDAQ:LPCN) Shares Five Years Ago Are Now Down 94% [Yahoo! Finance News] 6.8%
4/17 Form 8-K Lipocine Inc. For: Apr 17 6.2%
3/4 Lipocine Announces TLANDO™ PDUFA Date of August 28, 2020 6.1%
8/7 Q2/2019 6/30/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat 5.6%
2/5 Form 8-K Lipocine Inc. For: Feb 05 4.7%
Top News Decliners
11/11 Lipocine Receives Complete Response Letter for TLANDO™ from U.S. FDA -72.0%
11/13 Lipocine Announces Launch Of Public Offering Of Common Stock And Warrants -40.9%
3/13 Form 10-K Lipocine Inc. For: Dec 31 -18.9%
7/23 Form 8-K Lipocine Inc. For: Jul 23 -17.8%
11/12 Form 8-K Lipocine Inc. For: Nov 12 -14.5%
4/1 Form 8-K Lipocine Inc. For: Apr 01 -11.8%
4/21 Form 8-K Lipocine Inc. For: Apr 21 -10.2%
11/12 Form 8-K Lipocine Inc. For: Nov 11 -9.7%
1/13 TUESDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lipocine Inc. and Encourages Investors with Losses to Contact the Firm -8.9%
11/14 Form 424B5 Lipocine Inc. -8.5%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3